HVSEN BIOTECHNOLOGY CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.02 CNY | -5.20% |
|
-3.47% | -30.71% |
| 24/04 | Hvsen Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 03/04 | Hvsen Biotechnology Co., Ltd. announced a financing transaction | CI |
Wuhan Hvsen Biotechnology Co Ltd is a China-based company mainly engaged in the research, development, production and sales of veterinary drugs, feed and additives. The Companyâs main products include veterinary active pharmaceutical ingredients, veterinary chemical preparations, veterinary traditional Chinese medicine preparations, feed and additives and environmental improvers, such as tyvanicin tartrate, florfenicol powder, banqing granules and piglet composites pre-mixed feed, etc. The Company mainly conducts its businesses in the China market.
Sector
Pharmaceuticals
Calendar
27/08/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
10.02
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -30.71% | 238M | |
| +22.05% | 8.97B | |
| +20.25% | 3.61B | |
| -3.06% | 3.08B | |
| +17.40% | 1.66B | |
| -5.08% | 1.23B | |
| -31.85% | 1.15B | |
| -33.31% | 1.14B | |
| -25.27% | 985M | |
| +2.77% | 931M |
- Stock Market
- Equities
- 300871 Stock
- News Hvsen Biotechnology Co., Ltd.
- Wuhan Hvsen Biotechnology Sells $110 Million RMB Convertible Bonds
